Sodium stibogluconate (SSG, Pentostam) and meglumine antimoniate (MA, Glucantime) are
two antimonials that are widely used to treat cutaneous leishmaniasis (CL), but the relative …

Background: Cutaneous leishmaniasis (CL) is known for its wide variety of clinical
presentations. Children are frequent victims of the disease but studies regarding clinical …

INTRODUCTION: The treatment of mucosal leishmaniasis (ML) is difficult due to the toxicity
and route of administration of standard drugs. Miltefosine is an oral agent used for …

Cutaneous leishmaniasis (CL) treatment is painful, and cosmetic results are often
unsatisfying. Azithromycin has been reported to be effective in treatment of CL caused by …

Background. Cutaneous leishmaniasis is an ultimately self-curing disease for which
systemic therapy with pentavalent antimony (Sb) is effective but with side effects. We …

Pentavalent antimonials are the first-line drug treatment for American tegumentary
leishmaniasis. We report on a patient with chronic renal failure on hemodialysis who …

Thirty-two domestic dogs naturally infected with Leishmania infantum and showing viscero-
cutaneous signs of canine leishmaniasis were treated with aminosidine sulphate (11 dogs) …

Background: Cutaneous leishmaniasis is an endemic disease in developing countries. The
first-line drugs for its treatment are the pentavalent antimony compounds such as meglumine …

Background. To date, there is no specific literature available on the determinants for
therapeutic failure (TF) with meglumine antimoniate (MA) in Northwestern-Argentina. This …

This is an open study to compare the cure rate of cutaneous leishmaniasis caused by L.
major and treated with either paromomycin sulfate or intralesional injection of meglumine …